Compass Therapeutics, Inc. Liquidation Value
CMPX
Other
Cash & Equivalents
$30.64M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $30.64M
Total Obligations: -$23.80M
$6.85M
Per share: $0.04
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $30.64M
AR: $0
Total Obligations: -$23.80M
$6.85M
Per share: $0.04
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $30.64M
AR: $0
Inventory: $0
Total Obligations: -$23.80M
$6.85M
Per share: $0.04
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $6.85M | $0.04 |
| Liquid Liquidation Value | $6.85M | $0.04 |
| Operating Liquidation Value | $6.85M | $0.04 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $30.64M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $13.97M |
| Long-term Debt | N/A |
| Op. Lease Liability | $9.83M |
| Finance Lease | N/A |
| Shares Outstanding | 178.3M |
Explore all 128 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $30.64M | N/A | N/A | $1.58M | $13.97M | N/A | $9.83M | N/A |
| 2025-09-30 | $46.21M | N/A | N/A | $3.10M | $12.41M | N/A | $9.83M | N/A |
| 2025-06-30 | $22.86M | N/A | N/A | $2.60M | $13.86M | N/A | $9.90M | N/A |
| 2025-03-31 | $41.05M | N/A | N/A | $1.58M | $14.90M | N/A | $6.38M | N/A |
| 2024-12-31 | $43.48M | N/A | N/A | $2.25M | $8.87M | N/A | $6.63M | N/A |
| 2024-09-30 | $19.40M | N/A | N/A | $960,000 | $4.43M | N/A | $6.88M | N/A |
| 2024-06-30 | $19.40M | N/A | N/A | $1.19M | $9.51M | N/A | $1.09M | N/A |
| 2024-03-31 | $43.48M | N/A | N/A | $854,000 | $3.89M | N/A | $1.41M | N/A |
▼ Community Notes